Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. (Q54396812)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

adenosine triphosphate

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

immune function

1 reference

based on heuristic

inferred from title

Kaname Nakatani

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

author name string

Shugo Mizuno

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Takashi Hamada

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Masashi Kishiwada

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Masanobu Usui

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Hiroyuki Sakurai

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Masami Tabata

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Yuko Sakamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Junji Nishioka

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Yuichi Muraki

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Masahiro Okuda

11

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Tsutomu Nobori

12

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Shuji Isaji

13

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

Journal of Hepato-biliary-Pancreatic Sciences

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

18

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

226-32; discussion 232-4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

https://scigraph.springernature.com/pub.10.1007/s00534-010-0335-8

0 references

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Monitoring immune function during tacrolimus tapering in small bowel transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness.

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes

1 reference

https://api.crossref.org/works/10.1007%2FS00534-010-0335-8

21 January 2018

Identifiers

10.1007/S00534-010-0335-8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21165655

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54396812&oldid=2089947432"